Způsob stanovení závažnosti a prognózy B-buněčné chronické lymfocytární leukémie

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Science. Official publication website can be found on muni.cz.

Title in English	Method for magnitude and prognosis determination in B-cell chronic lymphocytic leukemia.
Authors	BRYJA Vítězslav KREJČÍ Pavel KAUCKÁ Markéta POSPÍŠILOVÁ Šárka MAYER Jiří KOZUBÍK Alois MALINOVÁ Karla KOTAŠKOVÁ Jana
Year of publication	2012
Type	Patent
MU Faculty or unit	Faculty of Science
Publisher
State	Czech Republic
Patent's number	303555
Description	Method for magnitude and prognosis determination of chronic lymphocytic leukemia in biological samples of the pacients is based on the assesment of the expression of at least one protein belonging to the group of membrane receptors Vangl2, Celsr1 and Frizzled7, cytoplazmatic proteins Dvl2, Dvl3 and Prickle1, casein kinase 1 epsilon and casein kinase 2 alfa and secreted ligand Wnt5a orat least one of the genes encoding protein protein belonging to the group of membrane receptors Vangl2, Celsr1 and Frizzled7, cytoplazmatic proteins Dvl2, Dvl3 and Prickle1, casein kinase 1 epsilon and casein kinase 2 alfa and secreted ligand Wnt5a.
Related projects:	Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies